Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phil Bowler Consulting was a small private consulting company established by Philip Bowler after his retirement from ConvaTec in 2020. The business appears to have focused on scientific and technical consulting related to wound care, infection, biofilms, and allied medical technology topics rather than developing proprietary therapeutics. Publicly available evidence links the founder to deep expertise in wound management and science and technology leadership in the medical products sector. The company was incorporated in the United Kingdom on August 12, 2020 and was dissolved on July 16, 2024. It does not appear to have operated as a drug-development biotech, pharma, or platform company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phil Bowler Consulting.